Safety and Efficacy at 48 Weeks After Switching From Tenofovir Disoproxil Fumarate (Tdf) to Tenofovir Alafenamide (Taf) in Chronic HBV Patients With Risk Factors for TDF Use
Journal article published in 2019 by
Maria Buti,
Pietro Lampertico,
Young-Suk Lim,
Kosh Agarwal 
,
Scott K. Fung,
Owen Tsang,
Magdy Elkhashab,
Jia-Horng Kao,
Jose Luis Calleja,
Mandana Khalili,
Natarajan Ravendhran,
Susanna Tan,
John F. Flaherty,
Anuj Gaggar,
Audrey H. Lau
and other authors.
,
Scott K. Fung,
Owen Tsang,
Magdy Elkhashab,
Jia-Horng Kao,
Jose Luis Calleja,
Mandana Khalili,
Natarajan Ravendhran,
Susanna Tan,
John F. Flaherty,
Anuj Gaggar,
Audrey H. Lau
and other authors.
